ZA9410189B - Novel stem cell factor formulations and methods - Google Patents

Novel stem cell factor formulations and methods

Info

Publication number: ZA9410189B
Authority: ZA; South Africa
Prior art keywords: stem cell; cell factor; methods; novel stem; factor formulations
Prior art date: 1993-12-22

Application number

ZA9410189A

Other languages

English (en)

Inventor

Susan I Hershenson

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-12-22

Filing date

1994-12-21

Publication date

1995-08-25

1994-12-21 Application filed by Amgen Inc filed Critical Amgen Inc

1995-08-25 Publication of ZA9410189B publication Critical patent/ZA9410189B/xx

Links

238000009472 formulation Methods 0.000 title abstract 4
239000000203 mixture Substances 0.000 title abstract 4
210000000130 stem cell Anatomy 0.000 title abstract 2
238000000034 method Methods 0.000 title 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 abstract 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 1
229930195725 Mannitol Natural products 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
235000013922 glutamic acid Nutrition 0.000 abstract 1
239000004220 glutamic acid Substances 0.000 abstract 1
HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 1
239000000594 mannitol Substances 0.000 abstract 1
235000010355 mannitol Nutrition 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

ZA9410189A 1993-12-22 1994-12-21 Novel stem cell factor formulations and methods ZA9410189B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US08/172,507 US6288030B1 (en)	1993-12-22	1993-12-22	Stem cell factor formulations and methods

Publications (1)

Publication Number	Publication Date
ZA9410189B true ZA9410189B (en)	1995-08-25

Family

ID=22627993

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA9410189A ZA9410189B (en)	1993-12-22	1994-12-21	Novel stem cell factor formulations and methods

Country Status (13)

Country	Link
US (4)	US6288030B1 (fr)
EP (1)	EP0732935B1 (fr)
CN (1)	CN1105575C (fr)
AT (1)	ATE173402T1 (fr)
AU (1)	AU696860B2 (fr)
CA (1)	CA2182970C (fr)
DE (1)	DE69414723T2 (fr)
DK (1)	DK0732935T3 (fr)
ES (1)	ES2123951T3 (fr)
IL (1)	IL112088A (fr)
NZ (1)	NZ278252A (fr)
WO (1)	WO1995017206A1 (fr)
ZA (1)	ZA9410189B (fr)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6267958B1 (en)	1995-07-27	2001-07-31	Genentech, Inc.	Protein formulation
GB9515839D0 (en) *	1995-08-02	1995-10-04	Q One Biotech Ltd	Feline stem cell factor
TW518219B (en) *	1996-04-26	2003-01-21	Chugai Pharmaceutical Co Ltd	Erythropoietin solution preparation
US6017876A (en)	1997-08-15	2000-01-25	Amgen Inc.	Chemical modification of granulocyte-colony stimulating factor (G-CSF) bioactivity
US6541033B1 (en)	1998-06-30	2003-04-01	Amgen Inc.	Thermosensitive biodegradable hydrogels for sustained delivery of leptin
US6420339B1 (en)	1998-10-14	2002-07-16	Amgen Inc.	Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility
US6245740B1 (en)	1998-12-23	2001-06-12	Amgen Inc.	Polyol:oil suspensions for the sustained release of proteins
US6500418B1 (en) *	1999-02-12	2002-12-31	The Washington University	Stimulating neutrophil function to treat inflammatory bowel disease
US8106098B2 (en)	1999-08-09	2012-01-31	The General Hospital Corporation	Protein conjugates with a water-soluble biocompatible, biodegradable polymer
US6472208B1 (en) *	1999-12-13	2002-10-29	Héma-Québec	Method of producing human IFN-α using sendai virus-infected hematopoietic stem cells
US20080152629A1 (en) *	2000-12-06	2008-06-26	James Edinger	Placental stem cell populations
EP2305795B1 (fr) *	2000-12-06	2019-07-03	Celularity, Inc.	Procédé de collecte de cellules souches placentaires
US7311905B2 (en) *	2002-02-13	2007-12-25	Anthrogenesis Corporation	Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
EP2316918B1 (fr)	2001-02-14	2015-07-01	Anthrogenesis Corporation	Placenta post-gravidique de mammifère, son utilisation et cellules souches placentaires correspondantes
US20030191056A1 (en)	2002-04-04	2003-10-09	Kenneth Walker	Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
JP3963786B2 (ja) *	2002-06-11	2007-08-22	富士通株式会社	情報処理装置
AU2003298775B2 (en)	2002-11-26	2008-07-17	Anthrogenesis Corporation	Cytotherapeutics, cytotherapeutic units and methods for treatments using them
CN1770976A (zh) *	2003-02-13	2006-05-10	人类起源公司	利用脐带血治疗患有疾病、紊乱或状况的个体的用途
GB0321337D0 (en) *	2003-09-11	2003-10-15	Massone Mobile Advertising Sys	Method and system for distributing advertisements
KR20120039065A (ko) *	2003-12-02	2012-04-24	셀진 코포레이션	혈색소병증　및　빈혈의　치료　및　관리를　위한　방법및　조성물
JP2007517042A (ja)	2003-12-30	2007-06-28	デュレクトコーポレーション	活性物質、好ましくはｇｎｒｈの制御放出のための、好ましくはｐｅｇおよびｐｌｇの混合物を含有するポリマーインプラント
MX2007015476A (es)	2005-06-14	2008-02-25	Amgen Inc	Formulaciones de proteina autoamortiguadoras.
WO2007016562A2 (fr) *	2005-07-29	2007-02-08	Amgen Inc.	Formulations inhibant l'agregation de proteines
NZ597304A (en)	2005-10-13	2013-06-28	Anthrogenesis Corp	Immunomodulation using placental stem cells
EP1976978A2 (fr)	2005-12-29	2008-10-08	Anthrogenesis Corporation	Co-culture de cellules souches placentaires et cellules souches provenant d'une seconde source
PL2471907T3 (pl)	2005-12-29	2019-07-31	Celularity, Inc.	Populacje komórek macierzystych łożyska
AR059066A1 (es)	2006-01-27	2008-03-12	Amgen Inc	Combinaciones del inhibidor de la angiopoyetina -2 (ang2) y el inhibidor del factor de crecimiento endotelial vascular (vegf)
EP1854478A1 (fr) *	2006-05-12	2007-11-14	Cytos Biotechnology AG	Composition vaccinale comprenant des conjugués nicotine-porteur
US8562972B2 (en)	2006-10-23	2013-10-22	Anthrogenesis Corporation	Methods and compositions for treatment of bone defects with placental cell populations
NZ612888A (en)	2007-02-12	2015-02-27	Anthrogenesis Corp	Treatment of inflammatory diseases using placental stem cells
US20100172830A1 (en) *	2007-03-29	2010-07-08	Cellx Inc.	Extraembryonic Tissue cells and method of use thereof
TWM322542U (en) *	2007-05-23	2007-11-21	Universal Scient Ind Co Ltd	Testing machine
US9200253B1 (en)	2007-08-06	2015-12-01	Anthrogenesis Corporation	Method of producing erythrocytes
KR20220122774A (ko) *	2007-09-26	2022-09-02	셀룰래리티 인코포레이티드	인간 태반 관류액으로부터의 혈관형성 세포
RU2536242C2 (ru)	2007-09-28	2014-12-20	Антродженезис Корпорейшн	Угнетение опухолей с помощью плацентарного перфузата человека и выделенных из плаценты человека вспомогательных натуральных клеток-киллеров
EP2217329B1 (fr) *	2007-11-07	2018-01-10	Anthrogenesis Corporation	Utilisation de sang provenant du cordon ombilical pour le traitement de complications liées à la naissance prématurée.
CA2734237C (fr) *	2008-08-20	2019-07-02	Anthrogenesis Corporation	Traitement d'un accident vasculaire cerebral a l'aide de cellules placentaires isolees
KR20200011604A (ko) *	2008-08-20	2020-02-03	안트로제네시스 코포레이션	개선된 세포 조성물 및 그의 제조 방법
CA2734446C (fr) *	2008-08-22	2017-06-20	Anthrogenesis Corporation	Methodes et compositions pour le traitement de deficits osseux au moyen de populations de cellules placentaires
RU2015130665A (ru) *	2008-11-19	2018-12-24	Антродженезис Корпорейшн	Амниотические адгезивные клетки
DK2375907T3 (da) *	2008-11-21	2019-06-11	Celularity Inc	Behandling af sygdomme, lidelser eller tilstande i lungerne under anvendelse af placentaceller
MX353489B (es)	2009-07-02	2018-01-16	Anthrogenesis Corp	Metodo para producir eritrocitos sin celulas alimentadoras.
DK3284818T3 (da) *	2010-01-26	2022-06-20	Celularity Inc	Behandling af knoglerelateret kræft ved hjælp af placenta stamceller
DK2556145T3 (en)	2010-04-07	2016-11-07	Anthrogenesis Corp	Angiogenesis using placental stem cells
EP2555783A1 (fr)	2010-04-08	2013-02-13	Anthrogenesis Corporation	Traitement de la sarcoïdose au moyen de cellules souches du sang placentaire
MX342995B (es)	2010-07-13	2016-10-21	Anthrogenesis Corp	Métodos de generar células asesinas naturales.
ES2630031T3 (es)	2010-09-28	2017-08-17	Aegerion Pharmaceuticals, Inc.	Un polipéptido de leptina pinnípedo-humano quimérico con solubilidad aumentada
WO2012092485A1 (fr)	2010-12-31	2012-07-05	Anthrogenesis Corporation	Amélioration de l'efficacité de cellules souches placentaires sous l'effet de molécules d'arn modulateur
ES2707579T3 (es)	2011-06-01	2019-04-04	Celularity Inc	Tratamiento del dolor usando citoblastos placentarios
WO2013055476A1 (fr)	2011-09-09	2013-04-18	Anthrogenesis Corporation	Traitement de la sclérose latérale amyotrophique au moyen de cellules souches placentaires
AU2014215458A1 (en)	2013-02-05	2015-08-13	Anthrogenesis Corporation	Natural killer cells from placenta
LT4209499T (lt)	2015-08-13	2024-11-25	Amgen Inc.	Antigeną surišančių baltymų įkrautas giluminis filtravimas

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4165370A (en)	1976-05-21	1979-08-21	Coval M L	Injectable gamma globulin
JPS5534001A (en) *	1978-08-28	1980-03-10	Noda Sangyo Kagaku Kenkyusho	Stabilization of sarcosine oxidase
US4783441A (en)	1979-04-30	1988-11-08	Hoechst Aktiengesellschaft	Aqueous protein solutions stable to denaturation
EP0035204B2 (fr)	1980-03-05	1991-05-22	Miles Inc.	Compositions pasteurisées de protéines thérapeutiquement actives
JPS5874617A (ja)	1981-10-28	1983-05-06	Green Cross Corp:The	人由来血液凝固第７因子含有水溶液の加熱処理方法
JPS58134991A (ja) *	1981-12-28	1983-08-11	Takeda Chem Ind Ltd	セラチオペプチタ−ゼの安定化法
JPS59134730A (ja)	1983-01-20	1984-08-02	Green Cross Corp:The	血液凝固第８因子の加熱処理法
FI86885C (fi)	1984-04-20	1992-10-26	Genentech Inc	Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
SE8501050D0 (sv)	1985-03-05	1985-03-05	Kabivitrum Ab	Biologically active fragments of human antihemophilic factor and method for preparation thereof
CA1292686C (fr)	1986-10-27	1991-12-03	Ze'ev Shaked	Compositions pharmaceutiques d'interleukine-2 recombinante et procede de fabrication
NZ226170A (en)	1987-09-18	1990-07-26	Ethicon Inc	Stable freeze-dried pharmaceutical composition containing epidermal growth factor
CA1329760C (fr) *	1987-10-29	1994-05-24	Ted C. K. Lee	Formulation de plasma et de proteines recombinantes dans des milieux a grande force ionique
US4877608A (en)	1987-11-09	1989-10-31	Rorer Pharmaceutical Corporation	Pharmaceutical plasma protein formulations in low ionic strength media
US5096885A (en)	1988-04-15	1992-03-17	Genentech, Inc.	Human growth hormone formulation
EP0381345B1 (fr)	1989-01-30	1994-07-13	Corint, Ltd.	Composition aqueuse à base de desmopressine-CMC
JPH02268681A (ja) *	1989-04-07	1990-11-02	Green Cross Corp:The	ウロキナーゼ前駆体の安定化方法及び乾燥製剤
JPH03505334A (ja) *	1989-04-11	1991-11-21	イミユノバイオロジー・リサーチ・インスチチユート・インコーポレーテツド	凍結乾燥されたペプチド製剤
SG59931A1 (en)	1989-10-16	1999-02-22	Amgen Inc	Stem cell factor
RU2212411C2 (ru)	1989-10-16	2003-09-20	Эмджен Инк.	Полипептид, обладающий гемопоэтической биологической активностью фактора стволовых клеток (варианты), днк (варианты), экспрессирующий вектор (варианты), фармацевтическая композиция для гемопоэтической терапии, способ получения полипептида и способ его использования (варианты)
SE465222C5 (sv)	1989-12-15	1998-02-10	Pharmacia & Upjohn Ab	Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
DE4001451A1 (de)	1990-01-19	1991-08-01	Octapharma Ag	Stabile injizierbare loesungen von faktor viii und faktor ix
AU8196891A (en)	1990-06-25	1992-01-23	Immunex Corporation	Mast cell growth factor
DK0618807T3 (da) *	1991-12-20	2003-03-03	Novo Nordisk As	Stabiliseret farmaceutisk formulering omfattende human væksthormon og histidin
US5192743A (en)	1992-01-16	1993-03-09	Genentech, Inc.	Reconstitutable lyophilized protein formulation
DE69329795T2 (de) *	1992-10-02	2001-07-05	Genetics Institute, Inc.	Zusammensetzung, welche den koagulationsfaktor viii beinhaltet; verfahren zu deren herstellung und die benutzung eines oberflächenaktiven stoffes als stabilisator

1993
- 1993-12-22 US US08/172,507 patent/US6288030B1/en not_active Expired - Fee Related
1994
- 1994-12-20 IL IL11208894A patent/IL112088A/en not_active IP Right Cessation
- 1994-12-21 EP EP95906058A patent/EP0732935B1/fr not_active Expired - Lifetime
- 1994-12-21 WO PCT/US1994/014739 patent/WO1995017206A1/fr not_active Ceased
- 1994-12-21 NZ NZ278252A patent/NZ278252A/en not_active IP Right Cessation
- 1994-12-21 CN CN94195012A patent/CN1105575C/zh not_active Expired - Fee Related
- 1994-12-21 ES ES95906058T patent/ES2123951T3/es not_active Expired - Lifetime
- 1994-12-21 CA CA002182970A patent/CA2182970C/fr not_active Expired - Fee Related
- 1994-12-21 AU AU14422/95A patent/AU696860B2/en not_active Ceased
- 1994-12-21 AT AT95906058T patent/ATE173402T1/de not_active IP Right Cessation
- 1994-12-21 DE DE69414723T patent/DE69414723T2/de not_active Expired - Lifetime
- 1994-12-21 ZA ZA9410189A patent/ZA9410189B/xx unknown
- 1994-12-21 DK DK95906058T patent/DK0732935T3/da active
1998
- 1998-06-29 US US09/106,891 patent/US5965522A/en not_active Expired - Fee Related
1999
- 1999-04-15 US US09/292,222 patent/US6020469A/en not_active Expired - Fee Related
2000
- 2000-12-20 US US09/748,592 patent/US20020013258A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2182970C (fr)	2000-11-28
IL112088A0 (en)	1995-03-15
AU696860B2 (en)	1998-09-17
HK1008815A1 (en)	1999-05-21
US5965522A (en)	1999-10-12
CN1142771A (zh)	1997-02-12
EP0732935B1 (fr)	1998-11-18
ATE173402T1 (de)	1998-12-15
IL112088A (en)	2001-04-30
US6288030B1 (en)	2001-09-11
DE69414723T2 (de)	1999-07-22
EP0732935A1 (fr)	1996-09-25
US20020013258A1 (en)	2002-01-31
WO1995017206A1 (fr)	1995-06-29
ES2123951T3 (es)	1999-01-16
CN1105575C (zh)	2003-04-16
DK0732935T3 (da)	1999-08-02
NZ278252A (en)	1998-04-27
US6020469A (en)	2000-02-01
DE69414723D1 (de)	1998-12-24
CA2182970A1 (fr)	1995-06-29
AU1442295A (en)	1995-07-10

Publication	Publication Date	Title
ZA9410189B (en)	1995-08-25	Novel stem cell factor formulations and methods
AU1777495A (en)	1995-11-16	Stable freeze-dried formulation comprising a protein; assay kit
WO1995013297A3 (fr)	1995-06-15	Compositions immunogenes ameliorees agissant contre la gastrine humaine 17
CA2191213A1 (fr)	1995-12-07	Souches de lactobacillus d'origine humaine, leurs compositions et leurs utilisations
BG103977A (en)	2000-11-30	Low molecular rotamase enzymic activity inhibitors
DE3586697D1 (en)	1992-11-05	Aktive thymopentin-analoga.
EP0182372A3 (fr)	1988-09-14	Polypeptides facteur VIII coagulant
KR0180256B1 (en)	1999-04-01	Bpc peptides, their preparation and use
MX9708426A (es)	1998-08-30	Polipeptido hk2 de variante estable.
AU6645294A (en)	1994-11-21	L-amino acid oxidase
IE873239L (en)	1988-06-01	Variants of hirudin
PH31320A (en)	1998-07-06	Fenbendazole formulations.
AU570572B2 (en)	1988-03-17	4,5-dihydro-4-oxo-2-((2-trans-phenylcyclopropyl) amino)-3- furancarboxylic acid derivatives
PH31219A (en)	1998-05-05	Stable lyophilized thiotepa composition.
BG103412A (en)	2000-06-30	Stabilized pharmaceutical compositions based on chinupristine and dalfopristine and their preparation
CA2115151A1 (fr)	1993-02-18	Proteines kinases pk40 et pk36 de tau/neurofilaments
NZ326769A (en)	2000-05-26	High-content famciclovir tablets
AU1518688A (en)	1988-11-17	Stable creatine amidinohydrolase mutants
AU7969187A (en)	1988-04-07	Amino acid composition
EP0219716A3 (fr)	1988-03-30	Agent immunosuppresseur
AU2170695A (en)	1995-09-14	Cloned glutamic acid decarboxylase
MX9705959A (es)	1997-11-29	Formulaciones para il-12.